T Wakabayashi, F Gomi, M Sawa, M Tsujikawa, … - British Journal of …, 2008 - bjo.bmj.com Results: The mean follow-up period was 19.2 months. Regression of the polypoidal lesions were
confirmed once in 29 eyes (94%) on ICGA and OCT. Some lesions recurred at the initial regions
(n = 5 eyes), at different regions connected to the branching vascular network (n = 4 ... Cited by 6 - Related articles - All 4 versions
- ►prsjournal.com TYY Lai, WM Chan, DTL Liu, FOJ Luk, DSC Lam - British Medical Journal, 2008 - bjo.bmj.com Results: The mean follow-up duration was 12.8 months. At 3 months, the mean logMAR BCVA
improved from 0.61 to 0.51 (p = 0.014), and the mean CFT reduced from 347 μm to 247 μm (p
= 0.015). Despite the visual and anatomical improvements, persistent polyps were ... Cited by 5 - Related articles - BL Direct - All 5 versions
F Gomi, Y Tano - Current Opinion in Opthalmology, 2008 - journals.lww.com Introduction Polypoidal choroidal vasculopathy (PCV) is a unique disease with choroidal vascular
abnormalities [1] that has been recognized increasingly in recent years as a clinical entity separate
from age-related macular degeneration (AMD) [2,3]. PCV is characterized by a branching ... Cited by 4 - Related articles - BL Direct - All 2 versions
N Kondo, S Honda, S Kuno, A Negi - Ophthalmology, 2009 - Elsevier We conducted an association analysis between CFH variants and PCV in a Japanese
population, genotyping 12 tag single nucleotide polymorphisms (SNPs)—including
rs3753394, rs800292 (I62V), and rs1061170 (Y402H)—that are highly representative of ... Cited by 3 - Related articles - All 24 versions
C Zuo, F Wen, J Li, Y Liu, M Li - Documenta Ophthalmologica, 2009 - Springer Abstract To investigate the changes in the multifo- cal electroretinography (ERG) after combined
intravitreal bevacizumab and photodynamic therapy (PDT) for polypoidal choroidal vasculopathy
(PCV) patients. Thirteen eyes of 13 patients were included in the study. The latencies and ... Cited by 1 - Related articles - All 2 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its introduction into
ophthalmic care 3 years ago. A PubMed search on 1 August 2008 revealed 51 ocular disease
processes that have been treated with bevacizumab. The majority of publications consist ... Cited by 3 - Related articles - All 23 versions
H Bessho, N Kondo, S Honda, S Kuno, A Negi - Molecular Vision, 2009 - pubmedcentral.nih.gov Using a candidate-gene approach, a recent case-control study identified a previously unknown
association between neovascular age-related macular degeneration (AMD) and the coding Met72Thr
variant in the pigment epithelium-derived factor (PEDF) gene in a Taiwan Chinese ... Cited by 1 - Related articles - All 5 versions
N Kondo, S Honda, S Kuno, A Negi - Ophthalmology, 2009 - Elsevier We performed an association analysis between PCV and polymorphisms across the
C2-CFB-RDBP-SKIV2L region in a Japanese population, genotyping 13 single nucleotide polymorphisms
(SNPs) spanning this region, including rs9332739 (E318D), rs547154, rs4151667 (L9H), ... Cited by 1 - Related articles - All 19 versions
JH Song, SH Byeon, SC Lee, HJ Koh, OW Kwon - Ophthalmologica, 2008 - content.karger.com Aims: To evaluate the short-term safety and efficacy of a single intravitreal bevacizumab injection
in patients with polypoidal choroidal vasculopathy (PCV). Methods: The records of patients treated
with intravitreal bevacizumab for PCV were retrospectively reviewed. All patients were ... Cited by 1 - Related articles - All 4 versions
